The Current and Evolving Landscape of First‐Line Treatments for Advanced Renal Cell Carcinoma

Agents targeting the vascular endothelial growth factor (VEGF) and its receptors (VEGFRs), as well as the mammalian target of rapamycin (mTOR) and immune checkpoint receptor programmed death 1 (PD‐1) signaling pathway have improved clinical outcomes for patients with advanced renal cell carcinoma (R...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncologist
Main Authors: Calvo, Emiliano, Porta, Camillio, Grünwald, Viktor, Escudier, Bernard
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons, Inc. 2018
Fag:
Genitourinary Cancer
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6519762/
https://ncbi.nlm.nih.gov/pubmed/30158285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0267
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker